These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Analysis of allele-specific RNA transcription in FSHD by RNA-DNA FISH in single myonuclei. Masny PS, Chan OY, de Greef JC, Bengtsson U, Ehrlich M, Tawil R, Lock LF, Hewitt JE, Stocksdale J, Martin JH, van der Maarel SM, Winokur ST. Eur J Hum Genet; 2010 Apr; 18(4):448-56. PubMed ID: 19888305 [Abstract] [Full Text] [Related]
4. FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients. Rijkers T, Deidda G, van Koningsbruggen S, van Geel M, Lemmers RJ, van Deutekom JC, Figlewicz D, Hewitt JE, Padberg GW, Frants RR, van der Maarel SM. J Med Genet; 2004 Nov; 41(11):826-36. PubMed ID: 15520407 [Abstract] [Full Text] [Related]
5. DUX4 promotes transcription of FRG2 by directly activating its promoter in facioscapulohumeral muscular dystrophy. Thijssen PE, Balog J, Yao Z, Pham TP, Tawil R, Tapscott SJ, Van der Maarel SM. Skelet Muscle; 2014 Nov; 4():19. PubMed ID: 25789155 [Abstract] [Full Text] [Related]
6. Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1. Gabellini D, D'Antona G, Moggio M, Prelle A, Zecca C, Adami R, Angeletti B, Ciscato P, Pellegrino MA, Bottinelli R, Green MR, Tupler R. Nature; 2006 Feb 23; 439(7079):973-7. PubMed ID: 16341202 [Abstract] [Full Text] [Related]
7. Direct interplay between two candidate genes in FSHD muscular dystrophy. Ferri G, Huichalaf CH, Caccia R, Gabellini D. Hum Mol Genet; 2015 Mar 01; 24(5):1256-66. PubMed ID: 25326393 [Abstract] [Full Text] [Related]
14. Skeletal muscle regeneration in facioscapulohumeral muscular dystrophy is correlated with pathological severity. Banerji CRS, Henderson D, Tawil RN, Zammit PS. Hum Mol Genet; 2020 Sep 29; 29(16):2746-2760. PubMed ID: 32744322 [Abstract] [Full Text] [Related]
15. Generation of isogenic D4Z4 contracted and noncontracted immortal muscle cell clones from a mosaic patient: a cellular model for FSHD. Krom YD, Dumonceaux J, Mamchaoui K, den Hamer B, Mariot V, Negroni E, Geng LN, Martin N, Tawil R, Tapscott SJ, van Engelen BG, Mouly V, Butler-Browne GS, van der Maarel SM. Am J Pathol; 2012 Oct 29; 181(4):1387-401. PubMed ID: 22871573 [Abstract] [Full Text] [Related]